Pulmonary Infections in the Era of Biological Agents

E-ISSN： 1875-6387|8|4|327-341

ISSN： 1573-398X

Source： Current Respiratory Medicine Reviews, Vol.8, Iss.4, 2012-08, pp. : 327-341

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New and Emerging Antifungal Agents: Impact on Respiratory Infections

By Feldmesser M.

American Journal of Respiratory Medicine, Vol. 2, Iss. 5, 2003-01 ,pp. : 371-383

Adis International

Access to resources Recommend Favorite

Novel Antimicrobial Agents for the Management of Maxillofacial and Neck Infections

Recent Patents on Anti-Infective Drug Discovery, Vol. 7, Iss. 2, 2012-08 ,pp. : 95-103

Bentham Science Publishers

Access to resources Recommend Favorite

Antibiotic Dosage Regimens in Respiratory Tract Infections in the Pharmacokinetic/Pharmacodynamic Era

Current Respiratory Medicine Reviews, Vol. 2, Iss. 1, 2006-02 ,pp. : 89-97

Bentham Science Publishers

Access to resources Recommend Favorite

BIOLOGICAL ENDPOINTS TO ASSESS PULMONARY AND CARDIOPULMONARY DAMAGE

Experimental Lung Research, Vol. 31, Iss. 6, 2005-07 ,pp. : 623-624

Informa Healthcare

Access to resources Recommend Favorite

Diagnosis and Treatment of Pulmonary Fungal Infections in Critically Ill Patients

Current Respiratory Medicine Reviews, Vol. 8, Iss. 3, 2012-06 ,pp. : 193-199

Bentham Science Publishers

Access to resources Recommend Favorite